Helix Biotech Biosimilar mRNA Vaccines

{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2027-09-30T23:59:59+01:00",
        "startDate": "2025-10-01T00:00:00+01:00"
      },
      "documents": [
        {
          "datePublished": "2025-09-04T13:53:39+01:00",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "053931-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/053931-2025"
        }
      ],
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Vaccines",
              "id": "33651600",
              "scheme": "CPV"
            }
          ],
          "deliveryAddresses": [
            {
              "country": "GB",
              "countryName": "United Kingdom",
              "region": "UK"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "goods",
      "milestones": [
        {
          "dueDate": "2025-10-01T23:59:59+01:00",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "relatedLots": [
        "1"
      ],
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-PPON-PCMD-6995-GBGZ",
          "name": "Helix Biotech, Inc."
        }
      ],
      "title": "Helix Biotech Biosimilar mRNA Vaccines",
      "value": {
        "amount": 150000,
        "amountGross": 180000,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PBMQ-7576-DVGW",
    "name": "UK Health Security Agency"
  },
  "date": "2025-09-04T13:53:39+01:00",
  "id": "053931-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-059422",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "E14 4PU",
        "region": "UKI42",
        "streetAddress": "10 South Colonnade"
      },
      "contactPoint": {
        "email": "commercial.preparednessandcountermeasures@ukhsa.gov.uk"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.gov.uk/government/organisations/uk-health-security-agency"
      },
      "id": "GB-PPON-PBMQ-7576-DVGW",
      "identifier": {
        "id": "PBMQ-7576-DVGW",
        "scheme": "GB-PPON"
      },
      "name": "UK Health Security Agency",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "US",
        "countryName": "United States",
        "locality": "Knoxville",
        "postalCode": "37918",
        "region": "US",
        "streetAddress": "1460 Breda Drive"
      },
      "contactPoint": {
        "email": "info@helix-biotech.com"
      },
      "details": {
        "scale": "sme",
        "vcse": false
      },
      "id": "GB-PPON-PCMD-6995-GBGZ",
      "identifier": {
        "id": "PCMD-6995-GBGZ",
        "scheme": "GB-PPON"
      },
      "name": "Helix Biotech, Inc.",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "C371747",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete",
        "suitability": {
          "sme": true
        }
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs). Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersTechnicalReasons"
      }
    ],
    "riskDetails": "A valid and current Cyber Essentials Certificate is required.",
    "status": "complete",
    "title": "Helix Biotech Biosimilar mRNA Vaccines"
  }
}